Ken Griffin’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-142,556
Closed -$2.12M 6954
2025
Q1
$2.12M Buy
142,556
+104,567
+275% +$1.55M ﹤0.01% 2540
2024
Q4
$503K Buy
+37,989
New +$503K ﹤0.01% 3989
2024
Q3
Sell
-312,081
Closed -$4.04M 6682
2024
Q2
$4.04M Buy
312,081
+302,886
+3,294% +$3.92M ﹤0.01% 1847
2024
Q1
$128K Sell
9,195
-86,564
-90% -$1.2M ﹤0.01% 4979
2023
Q4
$1.37M Buy
95,759
+92,068
+2,494% +$1.31M ﹤0.01% 2737
2023
Q3
$57.1K Sell
3,691
-44,584
-92% -$690K ﹤0.01% 5033
2023
Q2
$758K Sell
48,275
-7,741
-14% -$122K ﹤0.01% 3244
2023
Q1
$923K Buy
56,016
+36,273
+184% +$598K ﹤0.01% 3261
2022
Q4
$308K Sell
19,743
-678,082
-97% -$10.6M ﹤0.01% 4307
2022
Q3
$9.05M Buy
697,825
+296,059
+74% +$3.84M ﹤0.01% 1354
2022
Q2
$5.64M Buy
401,766
+58,083
+17% +$816K ﹤0.01% 1752
2022
Q1
$4.92M Sell
343,683
-18,335
-5% -$263K ﹤0.01% 2087
2021
Q4
$4.93M Sell
362,018
-37,960
-9% -$517K ﹤0.01% 2112
2021
Q3
$6.55M Buy
399,978
+76,288
+24% +$1.25M ﹤0.01% 1811
2021
Q2
$5.45M Buy
323,690
+110,412
+52% +$1.86M ﹤0.01% 2049
2021
Q1
$3.9M Sell
213,278
-140,122
-40% -$2.56M ﹤0.01% 2403
2020
Q4
$6.43M Buy
353,400
+231,403
+190% +$4.21M ﹤0.01% 1560
2020
Q3
$2.18M Buy
121,997
+15,394
+14% +$275K ﹤0.01% 2204
2020
Q2
$1.91M Sell
106,603
-98,434
-48% -$1.76M ﹤0.01% 2297
2020
Q1
$3.11M Buy
205,037
+108,154
+112% +$1.64M ﹤0.01% 1834
2019
Q4
$1.91M Sell
96,883
-98,211
-50% -$1.94M ﹤0.01% 2404
2019
Q3
$3.36M Buy
195,094
+25,788
+15% +$444K ﹤0.01% 1953
2019
Q2
$3M Buy
169,306
+121,028
+251% +$2.14M ﹤0.01% 2081
2019
Q1
$983K Sell
48,278
-528,806
-92% -$10.8M ﹤0.01% 2841
2018
Q4
$9.71M Buy
+577,084
New +$9.71M 0.01% 1020